WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2011142484) THERAPEUTIC AGENT FOR VIRAL INFECTIONS COMPRISING POLYALKYLENEIMINE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2011/142484    International Application No.:    PCT/JP2011/061602
Publication Date: 17.11.2011 International Filing Date: 13.05.2011
IPC:
A61K 31/785 (2006.01), A61K 9/127 (2006.01), A61K 47/24 (2006.01), A61K 47/28 (2006.01), A61K 47/36 (2006.01), A61P 31/12 (2006.01), A61P 31/22 (2006.01)
Applicants: NIPPON SHOKUBAI CO., LTD. [JP/JP]; 1-1, Koraibashi 4-chome, Chuo-ku, Osaka-shi, Osaka 5410043 (JP) (For All Designated States Except US).
MAITANI, Yoshie [JP/JP]; (JP) (For US Only).
HAYASHI, Kyoko [JP/JP]; (JP) (For US Only).
HASEGAWA, Hiroaki [JP/JP]; (JP) (For US Only).
KAI, Takashi [JP/JP]; (JP) (For US Only)
Inventors: MAITANI, Yoshie; (JP).
HAYASHI, Kyoko; (JP).
HASEGAWA, Hiroaki; (JP).
KAI, Takashi; (JP)
Agent: HIRAKI, Yusuke; Atago Green Hills MORI Tower 32F, 5-1, Atago 2-chome, Minato-ku, Tokyo 1056232 (JP)
Priority Data:
2010-112518 14.05.2010 JP
Title (EN) THERAPEUTIC AGENT FOR VIRAL INFECTIONS COMPRISING POLYALKYLENEIMINE
(FR) AGENT THÉRAPEUTIQUE POUR INFECTIONS VIRALES COMPRENANT UNE POLYALKYLÈNEIMINE
(JA) ポリアルキレンイミンを含むウイルス感染症治療薬
Abstract: front page image
(EN)Disclosed is a novel therapeutic agent for viral infections. Specifically disclosed is a pharmaceutical composition comprising polyalkyleneimine and at least one component selected from a neutrally or negatively charged liposome and chitosan. The use of a combination of polyalkyleneimine with a neutrally or negatively charged liposome and/or chitosan can reduce the cytotoxicity of polyalkyleneimine or increase the anti-viral activity of polyalkyleneimine.
(FR)L'invention concerne un nouvel agent thérapeutique pour infections virales. L'invention concerne spécifiquement une composition pharmaceutique comprenant une polyalkylèneimine et au moins un composant sélectionné parmi un liposome et un chitosane chargés de manière neutre ou négative. L'utilisation d'une polyalkylèneimine avec un liposome et/ou un chitosane chargés de manière neutre ou négative peut réduire la cytotoxicité de la polyalkylèneimine ou augmenter l'activité anti-virale de la polyalkylèneimine.
(JA) 本発明は新規なウイルス感染症治療薬を提供することを目的とする。本発明は、ポリアルキレンイミンと、中性もしくは負荷電のリポソームおよびキトサンから選択される少なくとも1種とを含む医薬組成物を提供する。ポリアルキレンイミンと中性もしくは負荷電のリポソームやキトサンを併用すると、ポリアルキレンイミンの細胞毒性を低減させるか、あるいは抗ウイルス活性を高めることができる。
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)